TAILAR MURPHY: Open Payments
NPI 1073143756 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,336 in 63 payments from 19 companies in 2025. Trend: 2023 $1,669 · 2024 $1,496 · 2025 $1,336
Food & beverage: $1,336
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $216 |
| Vanda Pharmaceuticals Inc. | 7 | $140 |
| Almatica Pharma LLC | 8 | $137 |
| ABBVIE INC. | 8 | $135 |
| Axsome Therapeutics, Inc. | 3 | $69 |
| Teva Pharmaceuticals USA, Inc. | 3 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $64 |
| Neurocrine BioSciences, Inc. | 4 | $64 |
| Collegium Pharmaceutical, Inc. | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
Products named: COBENFY, LOREEV XR, VRAYLAR, HETLIOZ, REXULTI, Auvelity, TRINTELLIX, INGREZZA.
Industry payments across NC — which companies pay providers there.
